Your Article Summary
Watson Prices $850 Million of Senior Unsecured Notes
Watson Pharmaceuticals, 08/19/09
Watson Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced the pricing of a debt offering of $450.0 million of 5.000% senior notes due 2014 and $400.0 million of 6.125% senior notes due 2019, for a total offering of $850.0 million in aggregate principal amount. The offering is expected to close on August 2009, subject to market conditions and other factors.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/17/09
A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09
Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09
Article Search
Sponsor


See Latest Articles


